Literature DB >> 32624188

The Right Ventricle in COVID-19 Patients.

Abdallah Fayssoil1, Hazrije Mustafic2, Nicolas Mansencal2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32624188      PMCID: PMC7280141          DOI: 10.1016/j.amjcard.2020.06.007

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
The acute coronavirus disease 2019 (COVID-19), due to Severe Respiratory Syndrome Coronavirus-2 causes an inflammatory state with cytokine release. Heart function may be affected, particularly in patients presenting with comorbidities and previous cardiovascular disease. In the meantime, the COVID-19 causes lung injury and acute respiratory distress syndrome (ARDS), a frequent complication in critically ill patients. The ARDS management requires specific lung ventilation strategies using recruiting maneuvers, prone position, high level of positive end-expiatory pressure and low tidal volumes. However, in intensive care unit, ARDS may be associated with hemodynamic instability and right ventricular (RV) dysfunction. The RV, in comparison with the left ventricle, discloses a thin wall with high dispensibility and acts normally in a low resistance system, in spontaneous ventilation. The afterload of the RV is determined by the pulmonary vascular resistance. In ARDS, the presence mechanical ventilation reduces the venous return, due the positive intrathoracic pressure. Also, in this situation, the RV afterload increases, secondary to the increase of the transpulmonary pressure and of the pulmonary vascular resistance and the vasoconstriction related to hypoxemia and hypercapnia. The onset of RV dysfunction and RV dilation (Figure 1 ) may also affect the left ventricular function and loading. This is explained by ventricular interdependence and paradoxical septum. In this case, a reduced cardiac output occurs, depressing the systemic perfusion and exposing the patient to RV ischemia. In addition, COVID-19 patients disclose a hyper coagulate state avec a significant incidence of pulmonary thrombotic complications, aggravated the RV afterload. The onset of right ventricular dysfunction and RV dilatation (acute cor pulmonale) is associated with excess mortality in ARDS. The acute cor pulmonale is classically associated with the following parameters: the driving pressure, the PaCO2 and the PaO2/FiO2 ratio. Finally, the RV function, measured by the tricuspid annular plane systolic excursion, the right ventricular fractional area change and the right ventricular longitudinal strain, is a significant predictive factor of mortality in COVID-19 infected patients. In this context, in addition with the left ventricular function analysis, it is of importance to check and assess the right ventricle in COVD-19 infected patients, particularly in critical situation.
Figure 1

COVID-19 pattern and acute respiratory distress syndrome. (A) Right ventricular dilation on computed tomography. (B) Severe pulmonary involvement detected by computed tomography. (C) Echocardiographic right ventricular dilation (apical 4-chamber view). (D) Depressed longitudinal right ventricular strain.

COVID-19 pattern and acute respiratory distress syndrome. (A) Right ventricular dilation on computed tomography. (B) Severe pulmonary involvement detected by computed tomography. (C) Echocardiographic right ventricular dilation (apical 4-chamber view). (D) Depressed longitudinal right ventricular strain.

Conflict of Interest

The authors have no conflicts of interest to declare.
  7 in total

1.  Value of standard echocardiography at the bedside for COVID-19 patients in intensive care units: a Japanese single-center analysis.

Authors:  Tomoo Nagai; Hitomi Horinouchi; Koichiro Yoshioka; Yoshihide Nakagawa; Yuji Ikari
Journal:  J Med Ultrason (2001)       Date:  2021-08-17       Impact factor: 1.878

2.  Association of coronary calcification with prognosis of Covid-19 patients without known heart disease.

Authors:  R Y Possari; H J Andrade-Gomes; V C Mello; E A Galdeano; L F Aguiar-Filho; M S Bittencourt; E V Ponte; L R Bertoche; L R S Caio; J D Rodrigues; F B Alcantara; M A C Freitas; J C G C Sarinho; N K Cervigne; W M Rodrigues; I Aprahamian
Journal:  Braz J Med Biol Res       Date:  2021-12-03       Impact factor: 2.590

Review 3.  Imaging Findings of COVID-19-Related Cardiovascular Complications.

Authors:  Eleni Nakou; Estefania De Garate; Kate Liang; Matthew Williams; Dudley J Pennell; Chiara Bucciarelli-Ducci
Journal:  Card Electrophysiol Clin       Date:  2021-10-30

4.  Echocardiographic predictors of mortality and morbidity in COVID-19 disease using focused cardiovascular ultrasound.

Authors:  Joanne Michelle D Gomez; Allison C Zimmerman; Jeanne du Fay de Lavallaz; John Wagner; Lillian Tung; Athina Bouroukas; Tai Tri P Nguyen; Jessica Canzolino; Alan Goldberg; Annabelle Santos Volgman; Tisha Suboc; Anupama K Rao
Journal:  Int J Cardiol Heart Vasc       Date:  2022-02-25

5.  Cardiac involvement in coronavirus disease 2019 assessed by cardiac magnetic resonance imaging: a meta-analysis.

Authors:  Shingo Kato; Mai Azuma; Kazuki Fukui; Sho Kodama; Naoki Nakayama; Hideya Kitamura; Eri Hagiwara; Takashi Ogura; Nobuyuki Horita; Ho Namkoong; Kazuo Kimura; Kouichi Tamura; Daisuke Utsunomiya
Journal:  Heart Vessels       Date:  2022-03-16       Impact factor: 1.814

Review 6.  Multimodality Imaging for Cardiac Evaluation in Patients with COVID-19.

Authors:  Erin Goerlich; Anum S Minhas; Monica Mukherjee; Farooq H Sheikh; Nisha A Gilotra; Garima Sharma; Erin D Michos; Allison G Hays
Journal:  Curr Cardiol Rep       Date:  2021-03-15       Impact factor: 2.931

Review 7.  Pathophysiological mechanisms of liver injury in COVID-19.

Authors:  Alexander D Nardo; Mathias Schneeweiss-Gleixner; May Bakail; Emmanuel D Dixon; Sigurd F Lax; Michael Trauner
Journal:  Liver Int       Date:  2020-11-29       Impact factor: 8.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.